Negev Capital is a psychedelic medical intervention investment fund with assets of USD$30+ million. The Company invests in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. They aim to support those early-stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP.
Company Details
- Employees
- 8
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.negevcap.com
- Keywords
- IT Consulting.
Negev Capital Questions
Negev Capital's website is http://www.negevcap.com
Negev Capital's LinkedIn profile is https://www.linkedin.com/company/negev-capital
Negev Capital has
8 employees.
View email and phone details for 8
employees at Negev Capital.
Negev Capital's industry is
Venture Capital and Private Equity Principals
Negev Capital's top competitors are
Bright Box,
Psymed Ventures,
Possible Ventures,
Negev Labs,
Lionheart Ventures,
Filament Health,
Atai Life Sciences,
Leafy Tunnel,
Reconnect Labs,
Jls Fund.
Negev Capital's categories are Venture Capital and Private Equity Principals
